B. Riley raised the firm’s price target on Wave Life Sciences (WVE) to $22 from $19 and keeps a Buy rating on the shares following the R&D day. The firm came away encouraged by deployment of Wave Life’s multiple platforms, “each of which could justify current valuation.”
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WVE: